Department of Tumor Biology, The Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
EMBO Mol Med. 2014 Dec;6(12):1509-11. doi: 10.15252/emmm.201404735.
MYC family oncoproteins (MYC, N‐MYC and L‐MYC) function as basic helix‐loop‐helix‐leucine zipper (bHLH‐Zip) transcription factors that are activated (i.e., overexpressed) in well over half of all human malignancies (Boxer & Dang, 2001; Beroukhim et al, 2010). In this issue of EMBO Molecular Medicine, Eilers and colleagues (Peter et al, 2014) describe a novel approach to disable MYC, whereby inhibition of the ubiquitin ligase HUWE1 stabilizes MIZ1 and leads to the selective repression of MYC‐activated target genes.
MYC 家族癌基因蛋白(MYC、N-MYC 和 L-MYC)作为碱性螺旋-环-螺旋-亮氨酸拉链(bHLH-Zip)转录因子,在超过一半的人类恶性肿瘤中被激活(即过度表达)(Boxer & Dang, 2001; Beroukhim et al, 2010)。在本期的《EMBO 分子医学》中,Eilers 及其同事(Peter 等人,2014 年)描述了一种新的抑制 MYC 的方法,即抑制泛素连接酶 HUWE1 可稳定 MIZ1,从而选择性地抑制 MYC 激活的靶基因。